These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2780137)

  • 1. Tin-protoporphyrin in the management of children with Crigler-Najjar disease.
    Rubaltelli FF; Guerrini P; Reddi E; Jori G
    Pediatrics; 1989 Oct; 84(4):728-31. PubMed ID: 2780137
    [No Abstract]   [Full Text] [Related]  

  • 2. Tin-protoporphyrin in the management of children with Crigler-Najjar disease.
    McDonagh AF
    Pediatrics; 1990 Jul; 86(1):151-2. PubMed ID: 2359679
    [No Abstract]   [Full Text] [Related]  

  • 3. Crigler-Najjar syndrome type II caused by a homozygous triple mutation [T-3279G, A(TA)7TAA, and H39D] of UGT1A1.
    Maruo Y; Topaloglu AK; Takahashi H; Mori A; Iwai M; Duzovali O; Yamamoto K; Matui K; Sato H; Takeuchi Y
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):236-9. PubMed ID: 16456422
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 2 Crigler-Najjar syndrome. Quantitation of ultrastructural data and evolution under therapy with phenytoin.
    Koch MM; Lorenzini I; Freddara U; Jezequel AM; Orlandi F
    Gastroenterol Clin Biol; 1978 Oct; 2(10):831-42. PubMed ID: 729981
    [No Abstract]   [Full Text] [Related]  

  • 5. Crigler-Najjar type II disease inheritance: a family study.
    Labrune P; Myara A; Hennion C; Gout JP; Trivin F; Odievre M
    J Inherit Metab Dis; 1989; 12(3):302-6. PubMed ID: 2515370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital nonobstructive, nonhemolytic jaundice: effect of tin-mesoporphyrin.
    Rubaltelli FF; Dario C; Zancan L
    Pediatrics; 1995 Jun; 95(6):942-4. PubMed ID: 7761229
    [No Abstract]   [Full Text] [Related]  

  • 7. Allelic heterogeneity of Crigler-Najjar type I syndrome: a study of 24 cases.
    Petit FM; Gajdos V; Francoual J; Capel L; Parisot F; Poüs C; Labrune P
    Clin Genet; 2004 Dec; 66(6):571-2. PubMed ID: 15521991
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual case of Crigler-Najjar disease in the adult. Classification into types I and II revisited.
    Duhamel G; Blanckaert N; Metreau JM; Préaux AM; Bouvry M; Fevery J; Berthelot P
    J Hepatol; 1985; 1(1):47-53. PubMed ID: 3932508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tin-protoporphyrin and neonatal jaundice.
    McDonagh AF
    J Photochem Photobiol B; 1987 Sep; 1(1):127-9. PubMed ID: 3149978
    [No Abstract]   [Full Text] [Related]  

  • 10. [Binding of bilirubin to serum albumin in Crigler-Najjar syndrome, type I].
    Ihara H; Aoki Y; Aoki T; Toyoda M
    Rinsho Byori; 1986 Sep; 34(9):1075-8. PubMed ID: 3795542
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of neonatal hyperbilirubinemia in rhesus monkeys by tin-protoporphyrin.
    Cornelius CE; Rodgers PA
    Pediatr Res; 1984 Aug; 18(8):728-30. PubMed ID: 6548009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sn-protoporphyrin: a consideration of the first clinical trial in human neonates.
    Stevenson DK; Vreman HJ
    Pediatrics; 1988 Jun; 81(6):881-2. PubMed ID: 3285317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolism of bilirubin. II. Primary changes in the metabolism of bilirubin].
    Palafox A; Valencia-Mayoral P; Kumate J
    Bol Med Hosp Infant Mex; 1988 Apr; 45(4):263-70. PubMed ID: 3293610
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged neonatal jaundice: a manifestation of heterozygote state for Crigler--Najjar syndrome?
    Odièvre M; Luzeau R; Alagille D
    J Pediatr Gastroenterol Nutr; 1982; 1(2):239-41. PubMed ID: 6821110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tin-protoporphyrin suppression of hyperbilirubinemia in the jaundiced Gunn rat.
    Davis DR; Bail SP
    Dev Pharmacol Ther; 1988; 11(5):281-7. PubMed ID: 3191820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A FURTHER CASE OF CRIGLER-NAJJAR DISEASE].
    LEVYMDE L; PORTELA R
    Rev Port Pediatr Pueric; 1965; 28():25-33. PubMed ID: 14293207
    [No Abstract]   [Full Text] [Related]  

  • 17. [FAMILIAL NON-HEMOLYTIC JAUNDICE WITH KERNICTERUS: CRIGLER-NAJJAR DISEASE].
    COHEN A
    Arch Argent Pediatr; 1963; 59():136-46. PubMed ID: 14219465
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed response to phenobarbital treatment of a Crigler-Najjar type II patient with partially inactivating missense mutations in the bilirubin UDP-glucuronosyltransferase gene.
    Ciotti M; Werlin SL; Owens IS
    J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):210-3. PubMed ID: 9932859
    [No Abstract]   [Full Text] [Related]  

  • 19. The liver in Crigler-Najjar syndrome, protoporphyria, and other metabolic disorders.
    Bloomer JR; Sharp HL
    Hepatology; 1984; 4(1 Suppl):18S-21S. PubMed ID: 6693070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital nonhemolytic hyperbilirubinemia].
    Casanueva V; Marín O; Calvo C; Cid X; Muñoz M
    Rev Chil Pediatr; 1983; 54(5):344-9. PubMed ID: 6424183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.